BACKGROUND: Immunosuppressive therapy after kidney transplant is necessary to prevent allograft rejection and it is the cause of several gastrointestinal (GI) disorders that have been scantily studied. OBJECTIVES: This study was aimed at investigating the influence of triple immunosuppressive therapy on GI transit in renal transplant patients by employing a biomagnetic technique. METHODS: Twenty-one renal transplant patients underwent triple therapy, which included either tacrolimus (TAC) or cyclosporin A (CsA) associated with prednisone and azathioprine. They were all evaluated, and fifteen other healthy individuals formed the control group. After a standardized meal, GI transit of magnetic markers was assessed using Alternating Current Biosusceptometry (ACB). RESULTS: Patients taking TAC had significantly accelerated gastric emptying and colonic arrival (p ≤ 0.001) when compared with those taking CsA and those in the control group. However, no differences were observed in small bowel transit among the groups studied. Overall, the inter-subject coefficients of variation for gastrointestinal transit parameters were higher for the TAC group and similar for the CsA and control groups. CONCLUSION: This study demonstrated that ACB is a suitable methodology when evaluating the influence of different immunosuppressive therapies on gastrointestinal transit after renal transplantation. Pronounced inter-individual variation was found in patients treated with tacrolimus, thus showing the prokinetic effect of this drug on GI motility. Studies of motility patterns in this population could be useful as complementary information toward determining the mechanisms and the relationship between motility and therapeutic doses.
BACKGROUND: Immunosuppressive therapy after kidney transplant is necessary to prevent allograft rejection and it is the cause of several gastrointestinal (GI) disorders that have been scantily studied. OBJECTIVES: This study was aimed at investigating the influence of triple immunosuppressive therapy on GI transit in renal transplant patients by employing a biomagnetic technique. METHODS: Twenty-one renal transplant patients underwent triple therapy, which included either tacrolimus (TAC) or cyclosporin A (CsA) associated with prednisone and azathioprine. They were all evaluated, and fifteen other healthy individuals formed the control group. After a standardized meal, GI transit of magnetic markers was assessed using Alternating Current Biosusceptometry (ACB). RESULTS:Patients taking TAC had significantly accelerated gastric emptying and colonic arrival (p ≤ 0.001) when compared with those taking CsA and those in the control group. However, no differences were observed in small bowel transit among the groups studied. Overall, the inter-subject coefficients of variation for gastrointestinal transit parameters were higher for the TAC group and similar for the CsA and control groups. CONCLUSION: This study demonstrated that ACB is a suitable methodology when evaluating the influence of different immunosuppressive therapies on gastrointestinal transit after renal transplantation. Pronounced inter-individual variation was found in patients treated with tacrolimus, thus showing the prokinetic effect of this drug on GI motility. Studies of motility patterns in this population could be useful as complementary information toward determining the mechanisms and the relationship between motility and therapeutic doses.
Authors: L A Corá; U Andreis; F G Romeiro; M F Américo; R B Oliveira; O Baffa; J R A Miranda Journal: Phys Med Biol Date: 2005-11-08 Impact factor: 3.609
Authors: Luciana A Corá; Madileine F Américo; Fernando G Romeiro; Ricardo B Oliveira; José Ricardo A Miranda Journal: Eur J Pharm Biopharm Date: 2009-05-29 Impact factor: 5.571
Authors: S S C Rao; M Camilleri; W L Hasler; A H Maurer; H P Parkman; R Saad; M S Scott; M Simren; E Soffer; L Szarka Journal: Neurogastroenterol Motil Date: 2011-01 Impact factor: 3.598
Authors: O Ozkaya; U Derici; N Buyan; A Dalgic; B Dalgic; E Cingi; M Kitapci; S Sindel; E Hasanoglu Journal: Transplant Proc Date: 2003-12 Impact factor: 1.066
Authors: Caio C Quini; Madileine F Américo; Luciana A Corá; Marcos Ff Calabresi; Matheus Alvarez; Ricardo B Oliveira; Jose Ricardo A Miranda Journal: J Biol Eng Date: 2012-05-15 Impact factor: 4.355